Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5484731 | 0.85 | PAOX (0.35) | PAOXALDH1A1POLBMAPTAPEX1 | |
| SCHEMBL28640747 | 0.73 | PAOX (0.39) | PAOXALDH1A1POLBMAPTAPEX1 | |
| SCHEMBL2010622 | 0.72 | PAOX (0.46) | PAOXALDH1A1POLBMAPT | |
| Hydrochloric Acid SCHEMBL2010036 | 0.71 | PAOX (0.44) | PAOXALDH1A1POLBMAPT | |
| SCHEMBL23344402 | 0.69 | — | — | |
| SCHEMBL12602739 | 0.69 | PAOX (0.59) | PAOXALDH1A1POLBMAPT | |
| SCHEMBL5500593 | 0.66 | BIRC2 (0.53) | PAOX | |
| SCHEMBL13993971 | 0.65 | — | — | |
| SCHEMBL11880993 | 0.65 | ALDH1A1 (0.60) | PAOXALDH1A1POLBMAPT | |
| SCHEMBL15042390 | 0.65 | PAOX (0.34) | PAOXALDH1A1APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3055304-A1 | NOVEL PYRIDYLOXYACETYL TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS NAMPT INHIBITORS | Eli Lilly and Company (US) | 2016-08-17 | — | — | EP | disclosed |
| WO-2015054060-A1 | NOVEL PYRIDYLOXYACETYL TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS NAMPT INHIBITORS | ELI LILLY AND COMPANY (US) | 2015-04-16 | — | — | WO | disclosed |